A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization
about
sameAs
Non thermal irreversible electroporation: novel technology for vascular smooth muscle cells ablationNon-acute percutaneous coronary intervention versus medical therapy in patients with ischaemic heart diseaseDrug-eluting stents versus bare metal stents for angina or acute coronary syndromesDrug-eluting stents versus bare metal stents for angina or acute coronary syndromesPercutaneous transluminal arterial angioplasty versus stenting for infrapopliteal arterial lesions in critical limb ischaemiaPrimary stenting versus primary balloon angioplasty for treating acute myocardial infarctionNeointimal expression of rapamycin receptor FK506-binding protein FKBP12: postinjury animal and human in-stent restenosis tissue characteristicsEverolimus-eluting stents in interventional cardiologyNext-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V)In-stent stenosis: pathology and implications for the development of drug eluting stentsInfluence of diabetes mellitus on heart failure risk and outcomeSirolimus increases tissue factor expression but not activity in cultured human vascular smooth muscle cells.Neoatherosclerosis: Coronary stents seal atherosclerotic lesions but result in making a new problem of atherosclerosisStent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014Everolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomesBiodegradable polymer Biolimus-eluting stent (Nobori®) for the treatment of coronary artery lesions: review of concept and clinical resultsThe perils of surrogate endpointsAn overview of clinical and experimental treatment modalities for port wine stainsNanoporous CREG-eluting stent attenuates in-stent neointimal formation in porcine coronary arteriesBioresorbable scaffolds: rationale, current status, challenges, and future.Bioresorbable Scaffolds: Current Evidences in the Treatment of Coronary Artery DiseasePercutaneous coronary intervention versus coronary artery bypass grafting for diabetics with multivessel coronary artery disease: the Korean Multicenter Revascularization Registry (KORR)Sirolimus-eluting stents for treatment of in-stent restenosis: immediate and late resultsInterventional therapy for coronary artery diseaseAntiplatelet therapy after percutaneous coronary interventionThe safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart diseaseCurrent medical management of chronic stable anginaRapid desensitization protocols for patients with cardiovascular disease and aspirin hypersensitivity in an era of dual antiplatelet therapyDrug-eluting stent: a review and updateClinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI)Impact of arterial remodelling and plaque rupture on target and non-target lesion revascularisation after stent implantation in patients with acute coronary syndrome: an intravascular ultrasound study.Dual antiplatelet therapy and drug eluting stents: a marriage of convenienceGuidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of CardiologyRedox regulation of the nutrient-sensitive raptor-mTOR pathway and complexExpansion of the Multi-Link Frontier™ coronary bifurcation stent: micro-computed tomographic assessment in human autopsy and porcine heart samplesImpact of the distance from the stent edge to the residual plaque on edge restenosis following everolimus-eluting stent implantationG-CSF Predicts Cardiovascular Events in Patients with Stable Coronary Artery DiseaseCan Platforms Affect the Safety and Efficacy of Drug-Eluting Stents in the Era of Biodegradable Polymers?: A Meta-Analysis of 34,850 Randomized IndividualsSurface Modification of Biodegradable Polymers towards Better Biocompatibility and Lower ThrombogenicityDialysis Patients with Implanted Drug-Eluting Stents Have Lower Major Cardiac Events and Mortality than Those with Implanted Bare-Metal Stents: A Taiwanese Nationwide Cohort Study
P2860
Q21562470-B063DA74-99D6-4E5D-A81E-47C5E53FCA4AQ24186673-7B6C1790-6961-43C8-AA05-FB3DDCF36FCFQ24186681-F305871C-7118-4977-BA45-B268EABE7186Q24235466-E7A49576-88A5-4A6E-886D-83337D24D3BEQ24235976-C653B104-5447-4C4A-9AD3-B113F59AB4FCQ24246929-BA3EF9FE-1FE8-448D-B855-FE697134F9A9Q24298705-038D4F10-5036-469F-8F63-5D952BA47043Q24630321-77F5096B-BEE3-4B14-BED1-AEBC09F54201Q24642679-20EFAC11-8FC4-4EF1-803C-1BC3C15210BBQ24674571-4C151B03-A930-45DB-BCC0-100854B3E9DDQ24800363-16824BB6-7814-41FA-B32B-172A459A5CE7Q24815293-6D82396E-B3FC-4F58-9866-250EE4BECE4DQ26774540-4CA8558A-8574-4567-98F8-420FAAD6CA11Q26785321-D18F8D95-EC6F-4B59-B79A-593F9C2C62DEQ26798582-7488B7C0-06FC-425A-BC11-F8D2D4DA9D2BQ26864540-9F8A5A2F-C5BA-45E7-B1F0-9FEBFFCD5514Q27025740-CD4D8B84-CC9B-4650-8913-C0C84D987683Q27026170-A945A341-DABF-4E9A-8BBE-3364CF2408DAQ27329486-B01D5820-4DEB-4ECF-A9FC-BC222D629168Q27690259-F3CE4F32-B317-4C8B-AE5A-D92E9F414A1BQ28076491-4FDC32C9-EC35-47D0-AA2D-AD7F1DD4D46CQ28174081-71867852-C4CF-4123-9774-DA3C809FB041Q28175715-366D5056-EB03-4C6B-989D-C14E1B4D72F8Q28193761-7896A6C5-A3D4-4FE4-8658-5814E82C1C9CQ28195049-3FCA5486-3CF5-4BA4-A646-9EC0BAC68A3DQ28200757-6507B3D8-3A98-403F-BEE8-B952C3241347Q28213164-11DF3811-9A35-4A98-9CE2-FC74E35126CCQ28213719-B5903853-68DF-43F6-A843-7CBDF41AA0DBQ28219254-F4C848FF-DC0A-45EC-97F3-4E29A8234EFCQ28219418-8F080AF4-6048-43AC-82AD-F580C8970AC8Q28221825-FB76BF0B-91FB-4299-9D8B-B284ECF55C91Q28222394-E3E84348-B27E-4D21-910B-776AAED8539DQ28239975-729F8D09-1FEE-4D97-BFEC-DE79C8039899Q28273915-843D2D84-A3F1-418C-95B4-383D6822DB4AQ28479223-67F10729-E041-43D4-8615-9405013A4DE7Q28544097-77BC1D5E-C329-4630-86C6-74447861230FQ28550861-BDF2689D-A87C-49DD-B533-223C0F5A2CF4Q28551120-84E4B59B-D430-4DB8-8772-1C2A85C77DFFQ28551353-25661C3E-5CCA-4D4E-AFE4-AE9AD6BA191EQ28552391-D6BBA1E1-CB56-4450-AB6D-E8BEFBCD6CB3
P2860
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
A randomized comparison of a s ...... for coronary revascularization
@ast
A randomized comparison of a s ...... for coronary revascularization
@en
A randomized comparison of a s ...... for coronary revascularization
@nl
type
label
A randomized comparison of a s ...... for coronary revascularization
@ast
A randomized comparison of a s ...... for coronary revascularization
@en
A randomized comparison of a s ...... for coronary revascularization
@nl
prefLabel
A randomized comparison of a s ...... for coronary revascularization
@ast
A randomized comparison of a s ...... for coronary revascularization
@en
A randomized comparison of a s ...... for coronary revascularization
@nl
P2093
P3181
P356
P1476
A randomized comparison of a s ...... for coronary revascularization
@en
P2093
Antonio Colombo
Ernesto Ban Hayashi
Ferenc Molnàr
Giulio Guagliumi
J Eduardo Sousa
Jean Fajadet
Marco Perin
Paul Barragan
Robert Falotico
P304
P3181
P356
10.1056/NEJMOA012843
P407
P577
2002-06-06T00:00:00Z